PharmaTimes -
March 2018

Last year the inaugural Pharma Fast 50 list showed us who the fastest-growing companies in the industry were, and we’re excited to be teaming up with Alantra again for a look at how things have changed for 2018 (p28).

Not only does the list tell the the industry which companies it needs to be keeping its eye on, but the accompanying analysis provides an in-depth look at the most important trends affecting the industry right now.

Elsewhere in the issue we look at how blockchain could change the pharma supply chain (p37), the latest trends in M&A (p36), the ups and downs of modern pharma R&D (p20) and an interesting collaborative project that aims to change health technology assessment in Duchenne muscular dystrophy (p22).

And don’t forget that March will be a big month for the PharmaTimes competitions – although both our Clinical Researcher competitions have now closed (with a record number of entries!) we’ll be launching the 2018 Communications Team of the Year awards and the Sales awards, as well as Marketer of the Year, which will be celebrating its 25th anniversary. We also have a brand new competition launching this year – Medical Excellence Awards for MSL, Scientific Affairs and Medical Affairs. Look out for more info in upcoming issues.

I hope you enjoy the issue.

March 2018 - magazine highlights

Thumbnail image for The Pharma Fast 50

The Pharma Fast 50

PharmaTimes presents Alantra’s annual look at the fastest-growing pharma companies

Thumbnail image for Securing the supply chain

Securing the supply chain

Counterfeit drugs are a billion-dollar industry. Could blockchain – the technology behind bitcoin – be the answer?

Thumbnail image for Patient Files: Hepatitis C

Patient Files: Hepatitis C

Mark Brunning’s hepatitis C is now under control, but at its worst the disease felt like “death from a thousand cuts”

Thumbnail image for Going local

Going local

Local population needs underpin the new NHS care models - so how can pharma help develop a tailored approach?

Thumbnail image for SmartPeople: Stuart Hill

SmartPeople: Stuart Hill

The business unit director, oncology, Merck UK & Ireland talks about the future of his company and the UK industry

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download